Inscription Capital LLC Sells 2,171 Shares of Cigna Group $CI

Inscription Capital LLC decreased its holdings in Cigna Group (NYSE:CIFree Report) by 34.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,192 shares of the health services provider’s stock after selling 2,171 shares during the period. Inscription Capital LLC’s holdings in Cigna Group were worth $1,154,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of the business. Capital Research Global Investors boosted its stake in Cigna Group by 140.2% in the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after acquiring an additional 1,855,897 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Cigna Group by 8.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after acquiring an additional 903,334 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in Cigna Group by 54.5% in the third quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after acquiring an additional 753,865 shares in the last quarter. M&T Bank Corp boosted its stake in Cigna Group by 1,299.3% in the fourth quarter. M&T Bank Corp now owns 635,706 shares of the health services provider’s stock valued at $174,965,000 after acquiring an additional 590,277 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in Cigna Group by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after acquiring an additional 414,834 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 2.5%

Shares of Cigna Group stock opened at $282.43 on Tuesday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The firm has a market capitalization of $74.43 billion, a price-to-earnings ratio of 12.73, a PEG ratio of 0.95 and a beta of 0.26. The firm’s 50 day simple moving average is $274.32 and its two-hundred day simple moving average is $276.85.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same quarter in the prior year, the business posted $6.64 EPS. Cigna Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts predict that Cigna Group will post 30.32 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is presently 28.13%.

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Piper Sandler lowered their target price on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Royal Bank Of Canada lowered their target price on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research note on Friday, February 6th. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Mizuho set a $325.00 target price on shares of Cigna Group in a research note on Friday, January 9th. Finally, Jefferies Financial Group lowered their target price on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research note on Monday, April 20th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $332.47.

Get Our Latest Stock Analysis on Cigna Group

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.